Synta Pharma 4Q Loss Narrows On Reduced R&D Spending – Wall Street Journal
March 11th, 2010 | 8:49 AM | by WSJ ||
Synta Pharma 4Q Loss Narrows On Reduced R&D Spending
Wall Street Journal Synta Pharmaceuticals Corp.'s (SNTA) fourth-quarter loss narrowed more than analysts expected as the biopharmaceutical company spent significantly less on … |
Read the original Article Here



Sorry, comments for this entry are closed at this time.